Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Krognes Steve E.

Over the trailing 90 days, Krognes Steve E. (Director at Guardant Health, Inc.) sold $1.2M of stock across 3 companies, per 11 SEC Form 4 transactions.

Role
Director
Companies
GH DNLI PLRX
Window
Trailing 90 days · 11 transactions · CIK 1666236
Net activity
−$1.2M ($0 bought · $1.2M sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
GHGuardant Health, Inc.8$1.2M−$1.2M
PLRXPLIANT THERAPEUTICS, INC.1$0
DNLIDenali Therapeutics Inc.2$0

Transactions (11)

DateSymbolTypeSharesValueDescription
2026-06-30GHSell155$0Exercise or conversion of derivative security
2026-06-30GHBuy155$0Exercise or conversion of derivative security
2026-06-17GHBuy4.2K$0Exercise or conversion of derivative security
2026-06-17GHSell4.2K$0Exercise or conversion of derivative security
2026-06-17GHBuy2.7K$0Grant, award or other acquisition
2026-06-11PLRXBuy70.0K$0Grant, award or other acquisition
2026-06-04GHSell9.3K$1.2MOpen market or private sale
2026-06-03DNLIBuy6.4K$0Grant, award or other acquisition
2026-06-03DNLIBuy19.2K$0Grant, award or other acquisition
2026-05-31GHBuy154$0Exercise or conversion of derivative security
2026-05-31GHSell154$0Exercise or conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Krognes's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free